Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Debled

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2011
Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)D Garbay, A Le Cesne, N Penel, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|March 23, 2007
[Bilateral ductal carcinoma in situ of the breast: independent events or bilateral disease?]G André, C Tunon-de-Lara, G Macgrogan, et al.
European Journal of Cancer (Oxford, England : 1990)|May 3, 2017
Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancerA Dezellus, P Barriere, M Campone, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2018
5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French studyA Ploquin, B Pistilli, E Tresch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2007
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trialL Mauriac, A Keshaviah, M Debled, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2018
Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patientsE Jacquet, A Lardy-Cléaud, B Pistilli, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2021
De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosisT Gaillard, M Carton, A Mailliez, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2022
Corrigendum to "De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): characteristics and prognosis" [Eur J Cancer 158 (2021) 181-188]T Gaillard, M Carton, A Mailliez, et al.
Breast (Edinburgh, Scotland)|November 2, 2019
CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC databaseP Gougis, M Carton, C Tchokothe, et al.
British Journal of Cancer|April 3, 2023
Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutationJ-S Frenel, A Lusque, S Delaloge, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2011
Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)D Garbay, A Le Cesne, N Penel, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|March 23, 2007
[Bilateral ductal carcinoma in situ of the breast: independent events or bilateral disease?]G André, C Tunon-de-Lara, G Macgrogan, et al.
European Journal of Cancer (Oxford, England : 1990)|May 3, 2017
Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancerA Dezellus, P Barriere, M Campone, et al.
European Journal of Cancer (Oxford, England : 1990)|April 7, 2018
5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French studyA Ploquin, B Pistilli, E Tresch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2007
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trialL Mauriac, A Keshaviah, M Debled, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2018
Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patientsE Jacquet, A Lardy-Cléaud, B Pistilli, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2021
De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosisT Gaillard, M Carton, A Mailliez, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2022
Corrigendum to "De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): characteristics and prognosis" [Eur J Cancer 158 (2021) 181-188]T Gaillard, M Carton, A Mailliez, et al.
Breast (Edinburgh, Scotland)|November 2, 2019
CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC databaseP Gougis, M Carton, C Tchokothe, et al.
British Journal of Cancer|April 3, 2023
Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutationJ-S Frenel, A Lusque, S Delaloge, et al.
Pageof 5